Correlation Between E L and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both E L and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining E L and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between E L Financial Corp and Cardiol Therapeutics Class, you can compare the effects of market volatilities on E L and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in E L with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of E L and Cardiol Therapeutics.
Diversification Opportunities for E L and Cardiol Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ELF-PF and Cardiol is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding E L Financial Corp and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and E L is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on E L Financial Corp are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of E L i.e., E L and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between E L and Cardiol Therapeutics
Assuming the 90 days trading horizon E L is expected to generate 5.2 times less return on investment than Cardiol Therapeutics. But when comparing it to its historical volatility, E L Financial Corp is 9.72 times less risky than Cardiol Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 158.00 in Cardiol Therapeutics Class on May 2, 2025 and sell it today you would earn a total of 50.00 from holding Cardiol Therapeutics Class or generate 31.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
E L Financial Corp vs. Cardiol Therapeutics Class
Performance |
Timeline |
E L Financial |
Cardiol Therapeutics |
E L and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with E L and Cardiol Therapeutics
The main advantage of trading using opposite E L and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if E L position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.The idea behind E L Financial Corp and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Cardiol Therapeutics vs. Medipharm Labs Corp | Cardiol Therapeutics vs. Avicanna | Cardiol Therapeutics vs. Medicenna Therapeutics Corp | Cardiol Therapeutics vs. Charlottes Web Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |